Search alternatives:
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
greater decrease » greatest decrease (Expand Search), greater increase (Expand Search), greater disease (Expand Search)
a decrease » _ decrease (Expand Search), _ decreased (Expand Search), _ decreases (Expand Search)
-
1341
-
1342
-
1343
-
1344
Version 2 of the Cochrane risk-of-bias tool for randomized controlled trials.
Published 2025Subjects: -
1345
Analysis of randomized controlled trials stratified based on treatment duration.
Published 2025Subjects: -
1346
-
1347
-
1348
-
1349
-
1350
Summary table showing analysis of randomized controlled trials stratified based on age groups.
Published 2025Subjects: -
1351
-
1352
S1 File -
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
1353
Experimental treatments and groups.
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
1354
Primers for RT-qPCR.
Published 2024“…Compared with LPS treatment alone, BA significantly mitigated the reduction in the TEER, decreased FD-4 flux permeability, increased the mRNA expression of ZO-1 and Occludin, and normalized the distribution of ZO-1 and Occludin in Caco2 cells. …”
-
1355
-
1356
-
1357
-
1358
-
1359
-
1360